16730 |
|
De Muro M.A. (ed.), Rapley R. (ed.) |
Gene Probes, Principles and Protocols |
2001 | •• |
16729 |
|
Shimkets R.A. |
Gene Expression Profiling: Methods and Protocols |
2004 | •• |
16728 |
|
Heiser W. (ed.) |
Gene Delivery to Mammalian Cells: Nonviral Gene Transfer Techniques (vol. 1) |
2003 | •• |
16727 |
|
Manser E. (ed.), Leung T. (ed.) |
GTPase Protocols: The Ras Superfamily |
2002 | •• |
16726 |
|
Nicola N. |
GM-CSF |
2000 | •• |
16725 |
|
Nicola N. |
GM-CSF Receptor |
2000 | •• |
16724 |
|
Vinay D., Kwon B. |
GIT Receptor |
2000 | •• |
16723 |
|
Wuyts A., Proost P, Van Damme J. |
GCP-2 |
2000 | •• |
16722 |
|
Nagata S. |
G-CSF |
2000 | •• |
16721 |
|
Nagata S. |
G-CSF Receptor |
2000 | •• |
16720 |
|
Smrcka A. (ed.) |
G Protein Signaling: Methods and Protocols |
2003 | •• |
16719 |
|
Valpuesta V. |
Fruit and Vegetable Biotechnology |
2002 | •• |
16718 |
|
Bock G. (ed.), Cohen D. (ed.), Goode J. (ed.) |
From Genome to Therapy: Integrating New Technologies With Drug Development |
2000 | •• |
16717 |
|
Greaves D., Schall T.J. |
Fractalkine |
2000 | •• |
16716 |
|
Blackburn C. (ed.), McClure P.J. (ed.) |
Foodborne Pathogens: Hazards, Risk Analysis, and Control |
2002 | •• |
16715 |
|
Pulciulran B., Dillon S. |
Flt-3 Ligand |
2001 | •• |
16714 |
|
Radbruch A. (ed.) |
Flow Cytometry and Cell Sorting |
2000 | •• |
16713 |
|
Givan A.L. |
Flow Cytometry: First Principles |
2001 • | •• |
16712 |
|
Ormerod M.G. |
Flow Cytometry |
1994 | •• |
16711 |
|
Chapman S.K., Reid G.A. (ed.) |
Flavoprotein Protocols |
1999 | •• |
16710 |
|
Nagata S. |
Fas |
2000 | •• |
16709 |
|
Nagata S. |
Fas Ligand |
2000 | •• |
16707 |
|
|
Exploring the Cell |
n/a | •• |
16706 |
|
Hromas R. |
Exodus-1/LARC/MIP-Ç alfa (SCYA 20) |
2001 | •• |
16705 |
|
Brown S.M., Hay J.G., Ostrer H. |
Essentials of Medical Genomics |
2003 | •• |
16704 |
|
Spivak J. |
Erythropoietin |
2000 | •• |
16703 |
|
Wilson J. (ed.), May G. (ed.) |
Epstein-Barr Virus Protocols |
2001 | •• |
16702 |
|
Williams T.J., Sabore I. |
Eotaxin |
2000 | •• |
16701 |
|
White J. |
Eotaxin 2 |
2000 | •• |
16700 |
|
Chaplin M.F., Bucke C. |
Enzyme Technology |
1990 | •• |
16699 |
|
Marangoni A. |
Enzyme Kinetics: A Modern Approach |
2003 | •• |
16698 |
|
Papathanassiu A., Grella D., Sim B. |
Endostatin |
2000 | •• |
16697 |
|
Galin F., Blalock J. |
Endorphins |
2000 | •• |
16696 |
|
Hester R. (ed.), Harrison R. (ed.) |
Endocrine Disrupting Chemicals |
1999 | •• |
16695 |
|
Saifutdinov R.G. |
Electron Paramagnetic Resonance in Biochemistry and Medicine |
2001 | •• |
16694 |
|
|
Everyday Practical Electronics (Vol. 33, No. 11. November 2004) |
2004 | •• |
16693 |
|
Nomiyama H., Yoshie O. |
ELC |
2000 | •• |
16692 |
|
Ahuja S.K. |
ECRF3 |
2000 | •• |
16691 |
|
McCammon A.J., Harvey S. |
Dynamics Of Proteins And Nucleic Acids |
1987 | •• |
16690 |
|
Seydel J., Wiese M. |
Drug-Membrane Interactions: Analysis, Drug Distribution, Modeling |
2002 | •• |
16689 |
|
Molema G., Meijer D.K.F. |
Drug Targeting |
2001 | •• |
16688 |
|
Wassarman P. (ed.), Keller G. (ed.) |
Methods in Enzymology (vol. 365). Differentiation of Embryonic Stem Cells |
2003 | •• |
16687 |
|
Sivertsson A. |
Detection and Analysis of Genetic Alterations in Normal Skin and Skin Tumours |
2002 | •• |
16686 |
|
Maj M. (ed.), Sartorius N. (ed.) |
Depressive Disorders |
2002 | •• |
16685 |
|
Ganz T. |
Defensins |
2000 | •• |
16684 |
|
Graham C.A. (ed.), Hill A. (ed.) |
DNA Sequencing Protocols |
2001 • | •• |
16683 |
|
Ashkenazi A. |
DcR3 |
2000 | •• |
16682 |
|
Piechocki R. |
Das berühmteste Bakterium. 100 Jahre Escherichia-coli-Forschung. |
1989 | •• |
16681 |
|
Ashkenazi A. |
DR4, DR5, DcR1, DcR2 |
2000 | •• |
16680 |
|
Gjerde D.T., Hanna Ch.P., Hornby D. |
DNA Chromatography |
2002 | •• |